Saturday, 18 September 2021 05:20

CDC-led study ranks the 3 vaccines approved for use in US for effectiveness

Rate this item
(0 votes)

A head-to-head study of all three authorized coronavirus vaccines in the United States finds the Moderna vaccine is slightly more effective than Pfizer's in real-life use in keeping people out of the hospital, and Johnson & Johnson's Janssen vaccine comes in third, but still providing 71% protection.

Pfizer's vaccine provided 88% protection against hospitalization, and Moderna's was 93% effective.

The US Centers for Disease Control and Prevention led a nationwide study of vaccination involving more than 3,600 adults hospitalized for Covid-19 between March and August.

"Among U.S. adults without immunocompromising conditions, vaccine effectiveness against Covid-19 hospitalization during March 11--August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%)," the team wrote in the CDC's weekly report on death and disease, the MMWR.

"Although these real-world data suggest some variation in levels of protection by vaccine, all FDA-approved or authorized Covid-19 vaccines provide substantial protection against Covid-19 hospitalization."

They found that the biggest difference between the vaccine made by Moderna and Pfizer/BioNtech's vaccine was driven by a decline that started about four months after people were fully vaccinated with Pfizer's vaccine.

"Differences in vaccine effectiveness between the Moderna and Pfizer-BioNTech vaccine might be due to higher mRNA content in the Moderna vaccine, differences in timing between doses (3 weeks for Pfizer-BioNTech versus 4 weeks for Moderna), or possible differences between groups that received each vaccine that were not accounted for in the analysis," the team wrote.

"A single dose of the Janssen viral vector vaccine had comparatively lower anti-SARS-CoV-2 antibody response and vaccine effectiveness against Covid-19 hospitalizations," they added.

"Understanding differences in vaccine effectiveness by vaccine product can guide individual choices and policy recommendations regarding vaccine boosters. All FDA-approved or authorized Covid-19 vaccines provide substantial protection against Covid-19 hospitalization."

CDC worked with researchers across the country to study 3,689 patients at 21 hospitals in 18 states for the study. They also looked at antibodies in the blood of 100 healthy volunteers after they'd been vaccinated with one of the three available vaccines.

 

CNN

December 28, 2024

Nigeria, China extend currency swap deal

Nigeria and China have renewed their 15 billion yuan ($2 billion) currency swap agreement, extending…
December 27, 2024

Bauchi governor accuses Tinubu of anti-North policies, warns of backlash

Bauchi State Governor Bala Mohammed has criticized President Bola Tinubu’s tax reform policies, calling them…
December 27, 2024

Scientists tracked 1,000 kids for 40 years. This was the No. 1 predictor of financial success

If you wanted to figure out what really matters for raising happy, successful kids, you’d…
December 28, 2024

Man accidentally drops iPhone into donation box, Temple refuses to return it

In a surprising incident in India, a man who accidentally dropped his iPhone into the…
December 27, 2024

Christmas Day attack on Benue community claims 11 lives

At least 11 people have been reportedly killed in Tor Azege community in Kwande Local…
December 28, 2024

What to know after Day 1038 of Russia-Ukraine war

WESTERN PERSPECTIVE Ukraine's Zelenskiy: North Koreans suffering battlefield losses, unprotected by Russian forces North Korean…
December 25, 2024

Stem cell therapy to correct heart failure in children could 'transform lives'

Renowned visionary English physician William Harvey wrote in 1651 about how our blood contains all…
December 17, 2024

Ademola Lookman named 2024 CAF Men’s Player of the year. These players won in other…

Ademola Lookman, the Super Eagles winger, was crowned the 2024 CAF Men’s Player of the…

NEWSSCROLL TEAM: 'Sina Kawonise: Publisher/Editor-in-Chief; Prof Wale Are Olaitan: Editorial Consultant; Femi Kawonise: Head, Production & Administration; Afolabi Ajibola: IT Manager;
Contact Us: [email protected] Tel/WhatsApp: +234 811 395 4049

Copyright © 2015 - 2024 NewsScroll. All rights reserved.